Rosa Coppolecchia

Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone.

P. Gurbel, U. Tantry, K. Bliden, 2010, Thrombosis research.

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

P. Rothwell, L. Ruilope, P. Gorelick, 2018, The Lancet.

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Deepak L. Bhatt, Sunil V. Rao, A. Budaj, 2022, Circulation.

Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting

T. Williamson, R. Carlton, B. Lennert, 2018, Journal of managed care & specialty pharmacy.